| |
| |
|
| Insider
Information: |
Kozin Marc D |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
40,195 |
|
|
Indirect Shares
|
39,000 |
|
|
| Direct
Value |
$7,291,256 |
|
|
|
Indirect Value
|
$6,084 |
|
|
| Total
Shares |
79,195 |
|
|
| Total
Value |
$7,297,340 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -100.0%
|
 41.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
UFP Technologies Inc |
UFPT |
Director |
2023-06-07 |
27,955 |
2010-11-18 |
0 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
Director |
2018-12-07 |
7,740 |
|
0 |
Premium* |
|
|
Endocyte Inc |
ECYT |
Director |
2018-12-21 |
0 |
2015-05-14 |
0 |
Premium* |
|
|
Salarius Pharmaceuticals, Inc |
SLRX |
Director |
2015-11-19 |
4,500 |
2015-11-19 |
0 |
Premium* |
|
|
Isleworth Healthcare Acquisition... |
ISLE |
Director |
2021-09-08 |
0 |
|
0 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2021-12-28 |
0 |
Premium* |
|
|
Notable Labs |
NTBL |
Director |
|
0 |
2023-01-01 |
39,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2014-01-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,000 |
|
- |
|
| ISLE |
Isleworth Healthcare Acqu... |
Director |
– • – |
2021-02-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
36,000 |
|
- |
|
| NTBL |
Notable Labs |
Director |
– • – |
2023-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
39,000 |
|
% |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2010-11-18 |
4 |
OE |
$4.13 |
$52,556 |
D/D |
11,388 |
11,388 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2010-11-18 |
4 |
S |
$11.08 |
$97,770 |
D/D |
(8,827) |
2,561 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2011-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
618 |
3,179 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2013-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
524 |
23,495 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2014-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
699 |
5,014 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-03-31 |
4 |
A |
$34.73 |
$9,655 |
D/D |
278 |
8,278 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-04-08 |
4 |
B |
$28.45 |
$85,350 |
D/D |
3,000 |
11,278 |
2.39 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2015-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
2,250 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
876 |
5,890 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-06-30 |
4 |
A |
$28.93 |
$9,663 |
D/D |
334 |
11,612 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-09-08 |
4 |
B |
$17.60 |
$52,800 |
D/D |
3,000 |
14,612 |
2.39 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,141 |
15,753 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-10-05 |
4 |
B |
$10.79 |
$51,792 |
D/D |
4,800 |
20,553 |
2.39 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2015-11-19 |
4 |
B |
$11.38 |
$51,219 |
D/D |
4,500 |
4,500 |
2.39 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
991 |
21,544 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,020 |
22,564 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2016-05-05 |
4 |
OE |
$5.06 |
$72,613 |
D/D |
13,390 |
19,280 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,500 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
794 |
20,074 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,859 |
24,423 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,353 |
25,776 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-12-30 |
4 |
A |
$1.53 |
$9,686 |
D/D |
6,331 |
32,107 |
0 |
- |
|
57 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
